Revista de la Sociedad Argentina de Diabetes
La obesidad es una enfermedad
Resumen
La obesidad es una enfermedad crónica, pandémica y multifactorial que se caracteriza por procesos fisiopatológicos que resultan en aumento del tejido adiposo disfuncional, lo que la asocia con múltiples comorbilidades y aumento de la mortalidad. Tiene, además, la característica fundamental de ser socialmente estigmatizante. En este sentido, es prioritaria la educación de la comunidad para mejorar la comprensión pública de la obesidad como enfermedad crónica y los riesgos del estigma sobre esta. La comunidad científica la considera como una enfermedad, es por ello que su reconocimiento representa una demanda sanitaria.
Palabras clave
Referencias
I. AACE/ACE Obesity Task Force. AACE/ACE Position statement on the prevention, diagnosis, and treatment of obesity. Endocr Pract 1998;4:297-350.
II. James WPT. Review. WHO recognition of the global obesity epi- demic. International Journal of Obesity 2008;32:S120-S126.
III. Bray GA, Kim KK, Wilding JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 2017;18 (7):715-23.
IV. National Heart, Lung, and Blood Institute. Clinical guideli- nes on the identi cation, evaluation treatment of overweight and obesity in adults. The Evidence Report. NIH publication 1998;98-4083.
V. Mechanick JI, Garber A, HandelsmanY, et al. American Associa- tion of Clinical Endocrinologists’ position statement on obesity and obesity medicine. Endocr Pract 2012;18(5):643.
VI. Garvey WT, Mechanick JI, Einhorn D. The American Association of Clinical Endocrinologists’ and the American College of En- docrinology: 2014 Advanced framework for a new diagnosis of obesity as a disease. Pract 2014 Sep;20(9):977-989.
VII. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disea- se: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) 2008;16:1161-77.
VIII. Milan Declaration: a call to action on obesity. Disponible en: https:// easo.org/2015-milan-declaration-a-call-to-actionon-obesity/.
IX. WHO European Charter for counteracting obesity 2006 Nov 16th.
Disponible en: http://www.euro.who.int.
X. Instituto Nacional de Estadística y Censos (INDEC). Cuarta En- cuesta
Nacional de Factores de Riesgo. Resultados de nitivos. 1o Ed. Ciudad Autónoma de Buenos Aires, Secretaría de Go- bierno de Salud de la Nación, 2019.
XI. Nyberg ST, Batty GD, Pentti J, Virtanen M, Alfredsson L, Frans- son EI. Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study. Lancet Pu- blic Health 2018;3: e490-e497.
XII. Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual participant-data meta-analysis of 239 prospective studies in four continents. The Lancet 2016;388(10046):776-86.
XIII. Ashkan Afshin and GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017;377:13-27.
XIV. Riaz H, Khan MS, Siddiqi TJ, Usman MS, ShH N, Goyal A. As- sociation between obesity and cardiovascular outcomes. A systematic review and meta-analysis of mendelian randomi- zation studies JAMA Netw Open 2018;1:e183788. doi:10.1001/ jamanetworkopen.2018.3788.
XV. Kenchaiah S, Evans J, Levy D, Wilson P, Benjamin E, Larson M, et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.
XVI. Whitlock G, et al. Body-mass index and cause-speci c mortality in 900 000 adults: collaborative analyses of 57 prospective stu- dies. Lancet 2009; 373:1083-96.
XVII. Abdullah A, Peeters A, de Courten M, Stoelwinder J. The mag- nitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies. Diabetes Research and Clinical Practice 2010;89(3):309-319. doi: 10.1016/j.diabres.2010.04.012.
XVIII. American Diabetes Association. Obesity management for the treatment of type 2 diabetes: standards of medical care in dia- betes 2021. Diabetes Care 2021 Jan; 44(Supplement 1): S100- S110.
XIX. Davies M. Management of hyperglycemia in type 2 diabetes. A consensus report by the American Diabetes Association (ADA) and the EuropeanAssociation for the Study of Diabetes (EASD). Diabetes Care 2018;41:2669-2701. doi: 10.2337/dci18-0033.
XX. Eisenberg D, Noria S, Grover B, Goodpaster K, Rogers AM; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS position statement on weight bias and stigma. Surg Obes Relat Dis 2019 Jun;15(6):814-821.
DOI: http://dx.doi.org/10.47196/diab.v56i1.523
Copyright (c) 2022 Sociedad Argentina de Diabetes Asociación Civil
